Johannes Gutenberg-Universität Mainz
- 6131/39-0
Labenz, Christian; Lammert, Frank; Galle, Peter R.
Reply to: "SEAL: Why was this approach not effective?"JOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. E27-E28
von Bargen, M. F.; Glienke, M.; Wilhelm, K. et al.
Report template from the German Society of Urology and the German Radiological Society for standardized, structured reporting of native computed tomography scans in the diagnosis of urinary stonesUROLOGIE. Bd. 62. H. 11. 2023 S. 1211-1214
Claessens, Joyce J. M.; Penson, Adriaan; Bronkhorst, Ewald M. et al.
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS-LATER studyCANCER. 2023
Iruzubieta, Paula; Bataller, Ramon; Arias-Loste, Maria Teresa et al.
Research Priorities for Precision Medicine in NAFLDCLINICS IN LIVER DISEASE. Bd. 27. H. 2. 2023 S. 535-551
Chevallay, Mickael; Berlth, Felix; De Manzoni, Giovanni et al.
Resection margin strategy in gastric cancer surgery: the European REMARCS (Resection MARgin for Cancer of the Stomach) surveyBRITISH JOURNAL OF SURGERY. Bd. 110. 2023
Iding, Aaron F. J.; Kremers, Bram M. M.; Pallares Robles, Alejandro et al.
Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management StudyTHROMBOSIS AND HAEMOSTASIS. Bd. 123. H. 08. 2023 S. 763-772
Meule, Adrian; Lieb, Klaus; Chmitorz, Andrea et al.
Resilience and depressive symptoms in inpatients with depression: A cross-lagged panel modelCLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2023
Knoll, Rebecca L.; Jarquin-Diaz, Victor Hugo; Klopp, Jonas et al.
Resilience and stability of the CF- intestinal and respiratory microbiome during nutritional and exercise interventionBMC MICROBIOLOGY. Bd. 23. H. 1. 2023
Roesner, Christoph; Tuescher, Oliver; Petrowski, Katja
Resilience as a predictor of habituationEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023
Harrison, Stephen A.; Bedossa, Pierre; Guy, Cynthia D. et al.
RESMETIROM TREATMENT HELPS RESTORE THYROID HORMONE LEVELS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRONASH TRIALHEPATOLOGY. Bd. 78. 2023 S. S1213-S1219